Home › Funds › Point72 Asset Management › TAK
Point72 Asset Management position in TAK
TAKEDA PHARMACEUTICAL CO LTD · Health Care
Latest position (Q2 2026)77.66K sh
Reported value held$1.24M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.30M | $21.29M | New |
| Q4 2022 | 2.78M | $43.41M | New |
| Q1 2023 | 2.53M | $41.67M | Reduce |
| Q2 2023 | 2.13M | $33.39M | Reduce |
| Q1 2024 | 206.10K | $2.86M | New |
| Q4 2024 | 26.60K | $352.18K | New |
| Q2 2026 | 77.66K | $1.24M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TAK
- Capital Research Global Investors 19.30M sh · $309.34M · Q2 2026
- Fidelity Management & Research (FMR) 9.60M sh · $153.88M · Q2 2026
- Morgan Stanley 6.99M sh · $112.13M · Q2 2026
- Goldman Sachs Group 5.13M sh · $82.15M · Q2 2026
- Arrowstreet Capital 3.73M sh · $59.84M · Q2 2026
- BlackRock Inc 3.69M sh · $59.12M · Q2 2026
- Renaissance Technologies 2.57M sh · $41.17M · Q2 2026
- D. E. Shaw & Co 2.05M sh · $32.85M · Q2 2026
- Northern Trust Corp 1.74M sh · $27.90M · Q2 2026
- AQR Capital Management 1.53M sh · $24.46M · Q2 2026
- Wells Fargo & Co 1.15M sh · $18.45M · Q2 2026
- Millennium Management 1.05M sh · $16.84M · Q2 2026